Evidence map›Paper›PMID 33325765›Full record

ReviewJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2021

Evolution of the stroke paradigm: A review of delayed recanalization.

Richard Camara, Nathanael Matei, John H Zhang

Abstract readComparative StudyReview
In one paragraph

Review in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Sonothrombolysis for Ischemic Stroke.Journal of cardiovascular development and disease · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review of major trials of acute blood pressure management in stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Richard CamaraDepartments of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, USA.
Nathanael MateiDepartments of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, USA.
John H ZhangDepartments of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, USA.ORCID 0000-0002-4319-4285

Funding

Neurovascular Protection for Early Brain Injury after SAHR01NS081740 · NINDS · LOMA LINDA UNIVERSITY · PI ZHANG, JOHN H · 2013 to 2017
$1.6M
NINDS NIH HHS R01 NS081740
6 · The paper itself

Abstract

While the time window for reperfusion after ischemic stroke continues to increase, many patients are not candidates for reperfusion under current guidelines that allow for reperfusion within 24 h after last known well time; however, many case studies report favorable outcomes beyond 24 h after symptom onset for both spontaneous and medically induced recanalization. Furthermore, modern imaging allows for identification of penumbra at extended time points, and reperfusion risk factors and complications are becoming better understood. Taken together, continued urgency exists to better understand the pathophysiologic mechanisms and ideal setting of delayed recanalization beyond 24 h after onset of ischemia.

Indexed as

BrainCerebral Blood VolumeCerebrovascular CirculationChildCombined Modality TherapyDiffusion Magnetic Resonance ImagingFemaleFibrinolytic AgentsHumansIschemic StrokeMagnetic Resonance AngiographyMaleMechanical ThrombolysisMiddle AgedReperfusionRisk FactorsFibrinolytic AgentsTissue Plasminogen ActivatorDelayed recanalizationpenumbraperfusionStroketPA

Identifiers

PMID33325765
PMCPMC8054720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.